Baxter International Inc. (BAX) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $17.59. It has a SharesGrow Score of 43/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of BAX = $25.54 (+45.2% from the current price, the stock appears undervalued). Analyst consensus target is BAX = $20 (+12.3% upside).
Valuation: BAX trades at a trailing Price-to-Earnings (P/E) of -9.2 (S&P 500 average ~25).
Financials: revenue is $11.2B, +3.8%/yr average growth. Net income is $957M (loss), growing at +12.4%/yr. Net profit margin is -8.5% (negative). Gross margin is 30.1% (-5.2 pp trend).
Balance sheet: total debt is $10.0B against $6.1B equity (Debt-to-Equity (D/E) ratio 1.63, leveraged). Current ratio is 2.31 (strong liquidity). Debt-to-assets is 49.9%. Total assets: $20.1B.
Analyst outlook: 15 / 36 analysts rate BAX as buy (42%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 78/100 (Pass), Growth 63/100 (Pass), Past 25/100 (Fail), Health 33/100 (Fail), Moat 49/100 (Partial), Future 40/100 (Partial), Income 10/100 (Fail).
